showed a trendP = 0.059
2 B) with regard to WT1 IgG Ab level in serous OC whereas patients with nonserous subtypes showed a trend to a poor clinical outcome correlated with high-WT1 IgG Ab level for PFS ( P = 0.059, Fig. 2 C).
2 B) with regard to WT1 IgG Ab level in serous OC whereas patients with nonserous subtypes showed a trend to a poor clinical outcome correlated with high-WT1 IgG Ab level for PFS ( P = 0.059, Fig. 2 C).